NCT07389603

Brief Summary

Metabolic syndrome is a cluster of risk factors, including abdominal obesity, high blood pressure, high triglycerides, and insulin resistance, that increase the risk of developing type 2 diabetes and cardiovascular disease. The prevalence of this syndrome is rising in Mexico. Recent research suggests that when we eat is as important as what we eat. Therefore, chrononutritional strategies such as time-restricted eating (TRE), where food intake is confined to a specific daily time window, have been developed and shown promising benefits. However, there are documented barriers to maintaining this nutritional strategy over time. Therefore, this study proposes that combining TRE with a psychochrononutritional program (integrating psychological, chronobiological, and nutritional components) will improve adherence to the nutritional strategy and lead to better health outcomes than only prescribing a specific eating window. To this end, 64 adults (18-60 years old) with metabolic syndrome will be recruited in Ciudad Guzmán, Jalisco, Mexico. The TRE intervention will last eight weeks and include two groups. One group will undergo a psychochrononutritional intervention, whereas the other will receive only instructions regarding the eating window. Within each group, two subgroups will be formed: one assigned to an 8-hour eating window, and the other to a 10-hour window. Before and after the intervention, anthropometric, biochemical (lipid profile and plasma glucose), clinical (blood pressure), and dietary assessments will be performed. We expect reductions in blood pressure, glucose, triglycerides, and waist circumference as well as better adherence in the psychochrononutritional intervention group.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
1mo left

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Dec 2025Jun 2026

Study Start

First participant enrolled

December 4, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 28, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 5, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Expected
Last Updated

February 18, 2026

Status Verified

January 1, 2026

Enrollment Period

4 months

First QC Date

January 28, 2026

Last Update Submit

February 15, 2026

Conditions

Keywords

Time restricted eatingEating BehaviorChrononutritionMetabolic syndromePsychochrononutrition

Outcome Measures

Primary Outcomes (6)

  • Waist circumference

    Waist circumference: A decrease in waist circumference is expected, ≤102 cm in men and ≤88 cm in women. Measured in centimeters using a measuring tape at the level of the navel, at the end of a normal exhalation.

    At the beginning (week 1) and end of the intervention (week 8).

  • Changes in Blood Pressure

    Blood Pressure: A decrease in blood pressure of ≤130/85 mmHg is expected. Measurement of systolic and diastolic blood pressure using a digital blood pressure monitor.

    At the beginning (week 1) and end of the intervention (week 8).

  • Changes in Glucose

    Glucose: A decrease in glucose level to \<110 mg/dL is expected. Measurement of fasting plasma glucose, measured through a venous blood sample obtained between 7:30 and 8:30 am and processed using an automated colorimetric method.

    At the beginning (week 1) and end of the intervention (week 8).

  • Changes in HDL cholesterol

    HDL cholesterol: An increase in its values is expected, with a normal range of \>40 mg/dL in men and \>50 mg/dL in woman. The increase will mean better cardiovascular outcomes. Measurement of HDL cholesterol measured through a venous blood sample obtained between 7:30 and 8:30 am and processed using an automated colorimetric method.

    At the beginning (week 1) and end of the intervention (week 8).

  • Changes in triglycerides levels

    Triglycerides: a decrease in values is expected, with a reference range \<150 mg/dL. The decrease will mean better cardiovascular outcomes. Measurement of serum triglycerides measured through a venous blood sample obtained between 7:30 and 8:30 am and processed using an automated colorimetric method.

    At the beginning (week 1) and end of the intervention (week 8).

  • Treatment Adherence

    Degree to which participants follow the recommendations of the intervention program, it will be measured by self-reporting. Adherence is expected four out of seven days a week.

    Monitoring for 8 weeks.

Secondary Outcomes (5)

  • Changes in Body weight

    At the beginning (week 1) and end of the intervention (week 8).

  • Body composition analysis

    At the beginning (week 1) and end of the intervention (week 8).

  • Changes in visceral fat

    At the beginning (week 1) and end of the intervention (week 8).

  • Mexican Diet Quality Index

    At the beginning (week 1) and end of the intervention (week 8).

  • Sleep quality

    At the beginning (week 1) and end of the intervention (week 8).

Study Arms (2)

Minimal intervention group

OTHER

Participants will be instructed to adhere to a specific eating window, with flexibility to select their daily eating-window start and end times, as long as they fall within an 8- or 10-hour period. This intervention will last 8 weeks, during which they are instructed to consume all their caloric intake within the established time window.

Behavioral: Time restricted eating

Grupo experimental

EXPERIMENTAL

Participants will be instructed to adhere to an 8- or 10-hour eating window, with flexibility to select their daily eating-window start and end times but must concentrate their caloric intake within that period. Additionally, the group receives a psychochrononutritional intervention consisting of weekly group sessions with an educational and behavioral focus for 8 weeks.

Behavioral: Time restricted eatingBehavioral: Psychochrononutritional intervention

Interventions

Behavioral and dietary intervention in which participants are instructed to consume all their food and caloric beverages within a fixed window (8 or 10 hours, depending on arm assignment). Outside of this window, only water or non-caloric beverages are permitted. The intervention will last 8 weeks.

Also known as: Time restricted feeding
Grupo experimentalMinimal intervention group

Participants will receive a structured psychochrononutritional intervention consisting of eight weekly sessions. The program will cover the following topics: * Chrononutrition: The internal clock of eating. * Food groups and healthy menu planning. * Portion control: Learning to measure appropriately. * Effects of sugary drinks. * Sleep and its impact on eating habits. * Social and cultural factors in eating habits. * The relationship between physical activity and nutrition. * Making informed nutritional decisions.

Grupo experimental

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18 to 60 years
  • Both sexes
  • Feeding window ≥14 h/day
  • Usual sleep duration \>6.5 h
  • Individuals diagnosed with metabolic syndrome who meet three or more of the criteria from Panel III of the National Cholesterol Education Program's Adult Treatment Guidelines:
  • Waist circumference: ≥102 cm for men, ≥88 cm for women
  • Triglycerides: ≥150 mg/dL or on treatment for hypertriglyceridemia
  • High-Density Lipoprotein (HDL) cholesterol: \<40 mg/dL for men, \<50 mg/dL for women
  • Blood pressure: systolic ≥130 mmHg and diastolic ≥85 mmHg or on treatment for hypertension
  • Fasting plasma glucose: ≥100 mg/dL
  • Individuals who provide informed consent

You may not qualify if:

  • (based on participant self-report unless medical records are available)
  • Pregnancy or lactation
  • Currently enrolled in a weight loss program
  • Current treatment with antidepressants, medications that affect glucose metabolism or appetite, or immunosuppressant therapy
  • History or presence of eating disorders
  • Sleep apnea
  • Elimination Criteria:
  • Participants who do not attend more than two sessions of the psychochrononutritional intervention program.
  • Participants who decide to withdraw their consent to continue in the study at any time for any reason.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro Universitario del Sur

Ciudad Guzmán, Jalisco, 49000, Mexico

RECRUITING

Related Publications (1)

  • Manoogian ENC, Wilkinson MJ, O'Neal M, Laing K, Nguyen J, Van D, Rosander A, Pazargadi A, Gutierrez NR, Fleischer JG, Golshan S, Panda S, Taub PR. Time-Restricted Eating in Adults With Metabolic Syndrome : A Randomized Controlled Trial. Ann Intern Med. 2024 Nov;177(11):1462-1470. doi: 10.7326/M24-0859. Epub 2024 Oct 1.

    PMID: 39348690BACKGROUND

MeSH Terms

Conditions

Metabolic SyndromeIntermittent FastingFeeding Behavior

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesFastingBehaviorBehavior, Animal

Study Officials

  • Yadira V Martínez Vázquez, PhD students

    University of Guadalajara

    STUDY CHAIR
  • Alma G Martínez Moreno, PhD

    University of Guadalajara

    STUDY CHAIR
  • César A Gómez Acosta, PhD

    Universidad de Pamplona

    STUDY CHAIR
  • Ana C Espinoza Gallardo, PhD

    University of Guadalajara

    STUDY CHAIR

Central Study Contacts

Ana P Zepeda Salvador, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD- Research Professor

Study Record Dates

First Submitted

January 28, 2026

First Posted

February 5, 2026

Study Start

December 4, 2025

Primary Completion

April 1, 2026

Study Completion (Estimated)

June 1, 2026

Last Updated

February 18, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

For security and data protection reasons, access to participants' identities is restricted. Sharing identification forms with external researchers contradicts the principle of purpose limitation of consent, which stipulates that personal information will be treated anonymously and privately, ensuring that no data that could re-identify subjects is disclosed outside the authorized research team.

Locations